SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 28 filers reported holding SILENCE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,669,873 | +78.5% | 2,104,875 | 0.0% | 3.04% | +60.4% |
| Q2 2023 | $11,576,813 | -11.3% | 2,104,875 | 0.0% | 1.90% | -25.4% |
| Q1 2023 | $13,050,225 | -59.3% | 2,104,875 | 0.0% | 2.54% | -55.1% |
| Q4 2022 | $32,099,344 | +52.0% | 2,104,875 | 0.0% | 5.66% | -10.6% |
| Q3 2022 | $21,122,000 | – | 2,104,875 | – | 6.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |